Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E. Winter(CeMM Research Center for Molecular Medicine), Giulio Superti‐Furga(Austrian Academy of Sciences), Uwe Rix(University of South Florida), Keiryn L. Bennett(Austrian Academy of Sciences), Jacques Colinge(Inserm), Florian P. Breitwieser(Johns Hopkins University), Karoline V. Gleixner(Medical University of Vienna), Manuela Gridling(Austrian Academy of Sciences), Scott M. Carlson(Duke University), Martin Bilban(Medical University of Vienna), Florian Grebien(University of Veterinary Medicine Vienna), Forest M. White(Center for Cancer Research), André C. Müller(Austrian Academy of Sciences), Peter Valent(Medical University of Vienna)
Cited by 96
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945